These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
397 related articles for article (PubMed ID: 10388657)
1. Changes in and discrepancies between cell tropisms and coreceptor uses of human immunodeficiency virus type 1 induced by single point mutations at the V3 tip of the env protein. Shimizu N; Haraguchi Y; Takeuchi Y; Soda Y; Kanbe K; Hoshino H Virology; 1999 Jul; 259(2):324-33. PubMed ID: 10388657 [TBL] [Abstract][Full Text] [Related]
2. Primary SIVsm isolates use the CCR5 coreceptor from sooty mangabeys naturally infected in west Africa: a comparison of coreceptor usage of primary SIVsm, HIV-2, and SIVmac. Chen Z; Gettie A; Ho DD; Marx PA Virology; 1998 Jun; 246(1):113-24. PubMed ID: 9656999 [TBL] [Abstract][Full Text] [Related]
3. Replacement of the V3 region of gp120 with SDF-1 preserves the infectivity of T-cell line-tropic human immunodeficiency virus type 1. Yonezawa A; Hori T; Takaori-Kondo A; Morita R; Uchiyama T J Virol; 2001 May; 75(9):4258-67. PubMed ID: 11287575 [TBL] [Abstract][Full Text] [Related]
4. Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptors. Sabri F; Tresoldi E; Di Stefano M; Polo S; Monaco MC; Verani A; Fiore JR; Lusso P; Major E; Chiodi F; Scarlatti G Virology; 1999 Nov; 264(2):370-84. PubMed ID: 10562499 [TBL] [Abstract][Full Text] [Related]
5. Amino acid substitutions in the V3 loop are responsible for adaptation to growth in transformed T-cell lines of a primary human immunodeficiency virus type 1. Harrowe G; Cheng-Mayer C Virology; 1995 Jul; 210(2):490-4. PubMed ID: 7618285 [TBL] [Abstract][Full Text] [Related]
6. Isolated human astrocytes are not susceptible to infection by M- and T-tropic HIV-1 strains despite functional expression of the chemokine receptors CCR5 and CXCR4. Boutet A; Salim H; Taoufik Y; Lledo PM; Vincent JD; Delfraissy JF; Tardieu M Glia; 2001 May; 34(3):165-77. PubMed ID: 11329179 [TBL] [Abstract][Full Text] [Related]
8. Generation and properties of a human immunodeficiency virus type 1 isolate resistant to the small molecule CCR5 inhibitor, SCH-417690 (SCH-D). Marozsan AJ; Kuhmann SE; Morgan T; Herrera C; Rivera-Troche E; Xu S; Baroudy BM; Strizki J; Moore JP Virology; 2005 Jul; 338(1):182-99. PubMed ID: 15935415 [TBL] [Abstract][Full Text] [Related]
9. HIV envelope proteins differentially utilize CXCR4 and CCR5 coreceptors for induction of apoptosis. Yao Q; Compans RW; Chen C Virology; 2001 Jun; 285(1):128-37. PubMed ID: 11414813 [TBL] [Abstract][Full Text] [Related]
10. Cell type-specific heterogeneity of the HIV-1 V3 loop in infected individuals: selection of virus in macrophages and plasma. Yamashita A; Yamamoto N; Matsuda J; Koyanagi Y Virology; 1994 Oct; 204(1):170-9. PubMed ID: 7916512 [TBL] [Abstract][Full Text] [Related]
11. Small amino acid sequence changes within the V2 domain can affect the function of a T-cell line-tropic human immunodeficiency virus type 1 envelope gp120. Koito A; Stamatatos L; Cheng-Mayer C Virology; 1995 Feb; 206(2):878-84. PubMed ID: 7856100 [TBL] [Abstract][Full Text] [Related]
12. A CXC chemokine receptor, CXCR5/BLR1, is a novel and specific coreceptor for human immunodeficiency virus type 2. Kanbe K; Shimizu N; Soda Y; Takagishi K; Hoshino H Virology; 1999 Dec; 265(2):264-73. PubMed ID: 10600598 [TBL] [Abstract][Full Text] [Related]
13. CD4-Dependent and CD4-independent utilization of coreceptors by human immunodeficiency viruses type 2 and simian immunodeficiency viruses. Liu HY; Soda Y; Shimizu N; Haraguchi Y; Jinno A; Takeuchi Y; Hoshino H Virology; 2000 Dec; 278(1):276-88. PubMed ID: 11112502 [TBL] [Abstract][Full Text] [Related]
14. [Biological characteristics of HIV-1 isolates circulating in China are linked to its env V3 loop sequence variability]. Hei FX; Hong KX; Song YH; Tang HL; Peng H; Xu JQ; Xing H; Shao YM Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(23):1968-72. PubMed ID: 15730807 [TBL] [Abstract][Full Text] [Related]
15. Relationship between V3 genotype, biologic phenotype, tropism, and coreceptor use for primary isolates of human immunodeficiency virus type 1. McDonald RA; Chang G; Michael NL J Hum Virol; 2001; 4(4):179-87. PubMed ID: 11694845 [TBL] [Abstract][Full Text] [Related]
16. Human immunodeficiency virus envelope V1 and V2 regions influence replication efficiency in macrophages by affecting virus spread. Toohey K; Wehrly K; Nishio J; Perryman S; Chesebro B Virology; 1995 Oct; 213(1):70-9. PubMed ID: 7483281 [TBL] [Abstract][Full Text] [Related]
17. Interactions of CCR5 and CXCR4 with CD4 and gp120 in human blood monocyte-derived dendritic cells. Xiao X; Kinter A; Broder CC; Dimitrov DS Exp Mol Pathol; 2000 Jun; 68(3):133-8. PubMed ID: 10816381 [TBL] [Abstract][Full Text] [Related]
18. Role of naturally occurring basic amino acid substitutions in the human immunodeficiency virus type 1 subtype E envelope V3 loop on viral coreceptor usage and cell tropism. Kato K; Sato H; Takebe Y J Virol; 1999 Jul; 73(7):5520-6. PubMed ID: 10364300 [TBL] [Abstract][Full Text] [Related]
19. CD4 receptor-dependent entry of human immunodeficiency virus type-1 env-pseudotypes into CCR5-, CCR3-, and CXCR4-expressing human alveolar macrophages is preferentially mediated by the CCR5 coreceptor. Park IW; Koziel H; Hatch W; Li X; Du B; Groopman JE Am J Respir Cell Mol Biol; 1999 May; 20(5):864-71. PubMed ID: 10226056 [TBL] [Abstract][Full Text] [Related]
20. Relationship between productive HIV-1 infection of macrophages and CCR5 utilization. Hung CS; Pontow S; Ratner L Virology; 1999 Nov; 264(2):278-88. PubMed ID: 10562492 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]